搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 小时
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise ...
At a median follow-up of 1.5 years, promising data from the 320 mg expansion cohort of phase 1/1b study shows no progression in patients with treatment-naïve CLL treated with sonrotoclax, a ...
6 小时
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell ...
All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...
5 小时
Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of ...
Odronextamab monotherapy led to complete responses in all patients with previously untreated follicular lymphoma evaluable for efficacy, per ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Murder suspect charged
Not guilty in subway death
Red-flag warnings in CA
On birthright citizenship
China deploys 90 ships
Targeted by a bomb threat
Cardiovascular disease risk
Quakes hit Alaska islands
US renews push to find Tice
Bans cancer causing solvents
Kanlaon volcano erupts
Syria's chemical weapons hit
Golden Globes nominations
China opens investigation
Baseball’s HOF inductees
Women drop lawsuit
Declines to lift gag order
Set to take witness stand
Deputy secretary of state
2024 word of the year
Travel ban on SK president
Swift’s Eras Tour ends
Ink distribution deal
Seeks to pause US ban
X removes image generator
Osprey flights paused again
Trust restructuring fails
TN grabs No. 1 in AP Top 25
NJ fines sports betting firms
反馈